Chronic renal insufficiency among Asian Indians with type 2 diabetes: I. Role of RAAS gene polymorphisms

BMC Medical Genetics

Volumn 7, Issue , 2006, Pages

  Prasad, Pushplata ^a   Tiwari, Arun K ^a   Kumar, K M Prasanna ^b   Ammini, A C ^c   Gupta, Arvind ^d   Gupta, Rajeev ^e   Sharma, A K ^e   Rao, A R ^f   Nagendra, R ^b   Chandra, Talluri Satish ^c   Tiwari, S C ^c   Rastogi, Priyanka ^e   Gupta, B Lal ^d   Thelma, B K ^a  

^a UNIVERSITY OF DELHI   (India)

^b Department of Endocrinology and Metabolism   (India)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^d Jaipur Diabetes Research Centre   (India)

^e Monilek Hospital and Research Centre   (India)

^f ICAR INDIAN AGRICULTURAL STATISTICS RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE SYNTHASE; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSINOGEN; CHYMASE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; RENIN;

ADULT; AGED; ALLELE; ARTICLE; ASIAN; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DISEASE PREDISPOSITION; ETHNOLOGY; FEMALE; GENETIC ANALYSIS; GENOTYPE; HAPLOTYPE; HUMAN; INDIAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PREDICTION; PROTEIN POLYMORPHISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GENE FREQUENCY; HUMANS; INDIA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RENAL INSUFFICIENCY, CHRONIC; RENIN-ANGIOTENSIN SYSTEM;

EID: 33745061275     PISSN: 14712350     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-7-42     Document Type: Article

References (49)

1. American Diabetes Association: Diabetic Nephropathy. Diabetes Care 2002, 25:S85-9.
2. Seaquist ER, goetz FC, Rich SS, Barbosa J: Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 1989, 320:1161-5.
3. Borch-Johnsen K, Norgaard K, Hommel E, Mathiesen ER, Jensen JS, Deckert T, Parving HH: Is diabetic nephropathy an inherited complication? Kidney Int 1992, 41:719-22.
4. Canani LH, Gerchman F, Gross JL: Familial clustering of diabetic nephropathy in Type2 diabetic patient. Diabetes 1999, 48:909-13.
5. Schmidt S, Schone N, Ritz E, the Diabetic Nephropathy Study Group: 1995. Association of ACE gene polymorphism and diabetic nephropathy? Kidney Int 1995, 47:1176-81.
6. Mizuiri S, Hemmi H, Inoue A, Yoshikawa H, Tanegashima M, Fushimi T, Ishigami M, Amagasaki Y, Ohara T, Shimatake H, Hasegawa A: Angiotensin-converting-enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus. Nephron 1995, 70-455-9.
7. Doi Y, Yoshizumi H, Lino K, Yamamoto M, Ichikawa K, Iwase M, Fujishima M: Association between a polymorphism in the angiotensin-converting-enzyme gene and microvascular complications in Japanese patients with NIDDM. Diabetologia 1996, 39:97-102.
8. Dudley CRK, Keavney B, Stratton IM, Turner RC, Ratcliffe PJ: U.K. prospective diabetes study XV: relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM. Kidney Int l995, 48:1907-11.
9. Marre M, Jeunemaitre X, Gallois Y, Rodier M, Chatellier G, Sert C, Dusselier L, Kahal Z, Chaillous L, Halimi S, Muller A, Sackmann H, Bauduceau B, Bled F, Passa P, Alhenc-Gelas F: Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENE-DIAB) study group. J Clin Invest 1997, 99:1585-95.
10. Cambien F, Alhenc-Gelas F, Herberth B, Andre JL, Rakotovao, R, Gonzales MF, Allegrini J, Bloch C: Familial ressemblance of plasma angiotensin converting enzyme level: the Nancy study. Am J Hum Genet 1988, 43:774-80.
11. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F: Angiotensin I converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 1993, 290:33-40.
12. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM: Molecular basis of human hypertension: role of angiotensinogen. Cell 1992, 71:169-80.
13. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes, estimates for the year 2000 and projections for 2030. Diabetes care 2004, 27:1047-53.
14. Rema M, Saravanan G, Deepa R, Mohan V: Familial clustering of diabetic retinopathy in south Indian Type 2 diabetic patients. Diabetic Medicine 2002, 19:910-16.
15. Vijay V, Snehalatha C, Sinha K, Lalitha S, Ramachandran A: Familial aggregation of diabetic kidney disease in type 2 diabetes in south India. Diabetes Res Clin Pract 1999, 43:167-71.
16. Vimaleswaran KS, Radha V, Ghosh S, Majumder PP, Deepa R, Babu HNS, Rao MRS, Mohan V: Peroxisome proliferators-activated receptor-co-activator-1 (PGC-1) gene polymorphisms and their relationship to Type 2 diabetes in Asian Indians. Diabetic Medicine 2005, 22:1516-21.
17. Anuradha S, Radha V, Deepa R, Hansen T, Carstensen B, Pedersen O, Mohan V: A prevalence amino acid polymorphism at Codon 98 (Ala98Val) of the hepatocyte nuclear factor-1 alpha is associated with maturity onset diabetes of the young and younger age at onset of Type 2 diabetes in Asian Indians. Diabetes Care 2005, 28:2430-5.
18. Kumaramanickavel G, Sripriya S, Ramprasad VL, Upadyay NK, Paul PG, Sharma T: Z-2 aldose reductase allele and diabetic retinopathy in India. Ophthalmic Genet 2003, 24:41-8.
19. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16:31-41.
20. Sambrook J, Fritsch EF, Maniatis: Molecular cloning: A laboratory manual. New York: Cold Spring Harbor Laboratory, 1989.
21. Steve Rozen, Helen J, Skaletsky: Primer3 on the WWW for general users and for biologist programmers. In Bioinformatics Methods and Protocols: Methods in Molecular Biology Edited by: Krawetz S, Misener S. Humana Press, Totowa, NJ; 2000:365-386.
22. Stephens M, Smith NJ, Donnelly P: A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001, 68:978-989.
23. Stephens M, Donnelly PP: Comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003, 73:1162-1169.
24. Gordon D, Finch SJ, Nothnagel M, Ott J: Power and sample size calculations for case-control genetic association tests when errors present: application to single nucleotide polymorphisms. Human Heredity 2002, 54:22-33.
25. Gordon D, Levenstien MA, Finch SJ, Ott J: Errors and linkage dis-equilibrium interact multiplicatively when computing sample sizes for genetic case-control association studies. Pacific Symposium on Biocomputing 2003:490-501.
26. Parving HH, Tarnow L, Rossing P: Genetics of diabetic nephropathy. J Am Soc Nephrol 1996, 7:2509-17. Review
27. Krolewski AS, Canessa M, Warram JH, Laffel LM, Christlieb AR, Knowler WC, Rand LI: Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 1988, 318:140-5.
28. Tagle R, Acevedo M, Vidt DG: Microalbuminuria: is it a valid predictor of cardiovascular risk? Cleve Clin J Med 2003, 70:255-61.
29. Herrington D: Eliminating the improbable: Sherlock Holmes and standards of evidence in the genomic age. Circulation 2005, 112:2081-4.
30. Hattersley AT, McCarthy MI: What makes a good genetic association study? Lancet 2005, 366:1315-23.
31. Tiwari AK, Deshpande SN, Rao AR, Bhatia T, Mukit SR, Shriharsh V, Lerer B, Nimagaonkar VL, Thelma BK: Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphism. Pharmacogenomics J 2005, 5:60-9.
32. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Ricard S, Poirer O, Parving HH: Angiotensin-II type I receptor gene pollymorphism and diabetic microangiopathy. Nephrol Dial Transplant 1996, 11:1019-23.
33. Doria A, Onuma T, Warram JH, Krolewski AS: Synergistic effect of angiotensin II type I receptor genotype and poor glycaemic control on risk of nephropathy in IDDM. Diabetologia 1997, 40:1293-9.
34. van Ittersum FJ, de Man AM, Thijssen S, de Knijff P, Slagboom E, Smulders Y, Tarnow L, Donker AJ, Bilo HJ, Stehouwer CD: Genetic polymorphisms of the renin-angiotensin system and complications of insulin-dependent diabetes mellitus. Nephrol Dial Transplant 2000, 15:1000-7.
35. Kunz R, Bork JP, Fritsche L, Ringel J, Sharma AM: Association between the angiotensin-converting enzyme-insertion/deletion polymorphism and diabetic nephropathy: a methodologic appraisal and systematic review. J Am Soc Nephrol 1998, 9:1653-63.
36. Staessen JA, Wang JG, Ginocchio G, Petrov V, Saavedra AP, Soubrier F, Vlietinck R, Fagard R: The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens 1997, 15:1579-92.
37. Fujisawa T, Ikegami H, Kawaguchi Y, Hamada Y, Ueda H, Shintani M, Fukuda M, Ogihara T: Meta-analysis of association of insertion/deletion polymorphism of anglotensin-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia 1998, 41:47-53.
38. Tarnow L, Gluud C, Parving HH: Diabetic nephropathy and the insertion/ deletion polymorphism of the angiotensin-converting enzyme gene. Nephrol Dial Transplant 1998, 13:1125-30.
39. Viswanathan V, Zhu Y, Bala K, Dunn S, Snehalatha C, Ramachandran A, Jayaraman M, Sharma K: Association between ACE gene polymorphism and diabetic nephropathy in south Indian patients. J Pancreas 2001, 2:83-7.
40. Doria A, Onuma T, Gearin G, Freire MBS, Warram JH, Krolewski AS: Angiotensinogen polymorphism M235T, hypertension and nephropathy in insulin dependent diabetes. Hypertension 1996, 27:1134-9.
41. Freire MBS, Onuma T, Orban T, Warram JH, Krolewski AS: Gender specific association of M235T polymorphism in angiotensinogen gene and diabetic nephropathy in NIDDM. Hypertension 1998, 31:896-9.
42. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Ricard S, Poirier O, Parving HH: Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathy. Diabetes 1996, 45:367-9.
43. Schmidt S, Giessell R, Bergis KH, Strojek K, Grzeszczak W, Ganten D, Ritz E: Angiotensinogen gene M235T polymorphism is not associated with diabetic nephropathy. The Diabetic Nephropathy Study Group. Nephrol Dial Transplant 1996, 11:1755-61.
44. Fogarty DG, Harron JC, Hughes AE, Nevin NC, Boherty CC, Maxwell AP: A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes 1996, 45:1204-8.
45. Epstein M: Aldosterone and the hypertensive kidney: its emerging role as a mediator of progressive renal dysfunction: a paradigm shift. J Hypertens 2001, 9(5):829-42.
46. Schjoedt KJ, Andersen S, Rossing P, Tarnow L, Parving HH: Aldosterone escape during blockade of the renin-angiotensinaldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate. Diabetologia 2004, 47(11):1936-9.
47. Zychma MJ, Zukowska-Szczechowska E, Lacka BI, Grzeszczak W: Angiotensinogen M235T and chymase gene CMA/B polymorphisms are not associated with nephropathy in type II diabetes. Nephrol Dial Transplant 2000, 15:1965-70.
48. Wolf G, Ziyadeh FN: The role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms. Am J Kidney Dis 1997, 29:153-63.
49. Weigert C, Brodbeck K, Klopfer K, Haring HU, Schleicher ED: Angiotensin II induces human TGF-beta 1 promoter activation: similarity to hyperglycaemia. Diabetologia 2002, 45:890-8.